THE PHALLONOX ENHANCEMENT PROTOCOL

Male intimate enhancement has long been treated as an afterthought in aesthetic medicine — dismissed, under-researched, or approached with a single-product mindset that ignores the anatomical complexity of the region. PHALLONOX™ represents a fundamentally different paradigm. Developed as the intimate subsystem of the MAXORIS™ masculine architecture, it is a structured, multi-zone protocol that treats enhancement not as a single injection but as a progressive engineering project.

The philosophy behind PHALLONOX is rooted in the broader AETHRAFORM Protocol™ and its biologic operating system, RECODEX™. Rather than chasing a single outcome, the protocol addresses form, function, and confidence simultaneously — integrating volumization with vascular support, nerve health, skin quality, and regenerative recovery. Each patient ascends through a personalized treatment arc designed for gradual, natural-looking results that settle and mature over time.

This is not a one-visit procedure. PHALLONOX is built on the principle that sustainable enhancement requires staged interventions, biologic support, and disciplined aftercare. The result is not merely a larger dimension, but a structurally refined, aesthetically balanced, and functionally optimized outcome engineered to last.

The PHALLONOX protocol organizes treatment into anatomically distinct zones — each with its own set of goals, techniques, and filler strategies. This zone-based architecture allows the protocol to address each area with precision, staging treatments so that results integrate naturally and irregularities are minimized between sessions.

Shaft — Girth and Contour

The shaft is the primary treatment zone for most patients seeking girth enhancement. The AETHRAFORM clinical team uses a tiered filler approach, beginning with reversible hyaluronic acid (HA) fillers to establish the treatment plane and assess patient response. For patients seeking longer-lasting results, semi-permanent collagen-stimulating scaffolds such as PMMA-based fillers can be introduced in subsequent sessions, built gradually over multiple visits. Volume is added conservatively and moulded for symmetry after each pass — a deliberate, controlled process that prioritizes natural proportion over aggressive augmentation.

Glans — Proportional Balance

When the glans appears proportionally small relative to the augmented shaft, micro-droplet techniques can be used to restore balance. HA micro-droplets are delivered in a precise peppering pattern for subtle, even volumization. For patients who have completed the HA trial and desire permanent correction, micro-drop silicone (administered off-label in a staged series) may be considered. Most patients with naturally proportionate anatomy do not require glans augmentation in early sessions.

Scrotum and Suspensory Complex

The scrotal region and suspensory ligament play an important role in overall aesthetic presentation. Neuromodulator treatments can smooth scrotal skin texture and create a more refined lower hang, while targeted ligament relaxation can improve flaccid presentation and visual length. These adjunctive treatments are typically introduced after initial girth sessions to refine the complete silhouette.

Beyond volumization, the PHALLONOX doctrine integrates several biologic modules that distinguish it from conventional filler-only approaches. These modules work in concert to optimize tissue integration, vascular health, nerve function, and skin quality across the treatment arc.

Volume Augmentation

The volumization tier offers three lines of filler matched to patient goals and desired longevity:

• First-line (HA fillers): Reversible, ideal for initial treatments and patients who want to trial results before committing to longer-lasting options.
• Second-line (PMMA/collagen scaffolds): Semi-permanent agents built gradually over multiple sessions for sustained structural enhancement.
• Third-line (autologous fat transfer): Reserved for select cases; less predictable in survival but an option for patients who prefer biologic-only augmentation.

Vascular and Nerve Support

Healthy blood flow and nerve integrity are essential for both filler integration and functional outcomes. The protocol incorporates PRP (platelet-rich plasma) combined with growth factors and exosomal therapies to promote angiogenesis, support nerve function, and enhance the biologic environment around injected materials. Shockwave therapy and vacuum devices are introduced post-procedure to improve microcirculation, promote filler evenness, and support long-term vascular health.

Skin and Pigment Care

The intimate region presents unique dermatologic considerations — from post-inflammatory hyperpigmentation risk to barrier recovery after injection. The PHALLONOX aftercare protocol includes a curated skincare regimen using Emer Skin™ products designed to accelerate barrier repair, suppress pigment irregularities, and maintain skin health throughout the treatment arc. Patients with deeper skin tones receive additional pigment control measures initiated once the skin is fully intact.

Regenerative IV Therapies

The RE:SKN™ intravenous programmes can be scheduled around filler sessions to support systemic healing and performance. These IV protocols are timed to specific phases of the treatment arc:

• CORE — GENESIS™: Administered pre-procedure to prime the immune system, reduce oxidative stress, and reset mitochondrial function with NAD+, glutathione, and targeted peptides.
• PRIME: Delivered on the day of treatment to calm neuro-inflammation, reduce anxiety, and suppress pigment formation.
• STABILIS: Initiated post-procedure to support collagen alignment, angiogenesis, and balanced immune response during the critical healing window.

Every PHALLONOX treatment begins with a comprehensive private consultation. The AETHRAFORM clinical team evaluates each patient’s anatomy, discusses goals — including girth, proportional balance, and aesthetic refinement — and sets realistic expectations. Multiple sessions and touch-ups are typical; minor irregularities and transient nodularity are expected parts of the process that resolve or are corrected over time.

A staged treatment plan is outlined during consultation. Most patients begin with reversible HA fillers as a first-line trial, with semi-permanent options introduced once the patient is confident in the direction and outcome. Adjunctive modules — including vascular support, shockwave therapy, and neuromodulator refinements — are layered in based on individual goals and anatomy.

Day-of-Procedure

On the day of treatment, the procedure area is prepared with clinical-grade antisepsis. Topical anaesthetic is applied for 30 to 40 minutes, followed by a nerve block for complete comfort during the procedure. Filler is delivered through precise, controlled injection techniques — linear threading and fanning along the shaft, with micro-droplet patterns for the glans when indicated. Volumes are built conservatively, and the tissue is moulded gently after each pass for symmetry and contour.

If PRP or exosomal therapies are part of the protocol, these are administered following filler placement to enhance the biologic integration environment. Each session concludes with 10 to 15 minutes of low-energy shockwave therapy to boost microcirculation and promote even filler distribution. The entire procedure is performed with meticulous technique and complete discretion.

Recovery in the PHALLONOX protocol is not passive — it is an actively engineered phase designed to optimize filler integration, accelerate healing, and support functional return. The protocol prescribes a structured recovery regimen that includes targeted supplements, skincare, device protocols, and optional peptide therapies.

Post-Procedure Support

A tailored medication and supplement programme supports comfort and healing through the initial recovery window:

• Pain management: Non-platelet-inhibiting analgesics for comfort without compromising healing.
• Edema control: Optional anti-inflammatory support to reduce swelling and bruising in the first week.
• Vascular support: Medication to maintain healthy hemodynamics and aid filler integration, initiated the evening of the procedure.
• Bruise modulators: Arnica and botanical supplements to reduce ecchymosis and soreness.
• Topical barrier care: Protective ointment applied to entry sites for the first 24 to 48 hours.

Device-Assisted Recovery

Beginning in weeks two to three (once any bruising has resolved), patients incorporate low-energy shockwave sessions and vacuum device protocols into their recovery. Shockwave therapy is typically performed one to two times per week for six sessions, targeting improved circulation and filler evenness. Vacuum device use begins at the same stage, used twice daily for four weeks to support tissue remodeling and vascular health. These devices are not optional add-ons — they are integral components of the PHALLONOX recovery architecture.

Peptide Protocols

For patients who elect the advanced regenerative tier, The protocol may prescribe targeted peptide stacks to accelerate healing and support performance:

• Healing and vascular support: Peptides that promote angiogenesis, fibroblast migration, wound healing, and collagen production — administered during the first several weeks of recovery.
• Performance and libido support: Melanocortin agonists and neuropeptides that complement the vascular protocol and support sexual confidence during and after the treatment arc.

All peptide protocols are prescribed off-label and discussed in detail during consultation, including risks, benefits, and the need for baseline labs when used over extended periods.

The PHALLONOX aftercare timeline is structured around specific healing milestones. Patients receive a detailed aftercare guide and are monitored through scheduled follow-up visits to ensure optimal progress.

Days 0 – 2: Acute Recovery

Expect edema and bruising at their peak. Cool compresses are applied for 10 minutes three times daily. Red-light therapy is applied twice daily to accelerate tissue repair. Protective ointment is maintained on entry sites. Activity is limited to gentle walking — patients should avoid sexual activity, strenuous exercise, hot tubs, saunas, and swimming.

Days 3 – 7: Early Healing

Bruising begins to fade. Gentle moulding may be performed if instructed by the AETHRAFORM clinical team. Pigment control products are introduced for patients prone to hyperpigmentation once the skin is visibly intact. Light exercise is acceptable; high-impact activity should be avoided.

Week 2: Contour Emergence

Most swelling has resolved and contour definition becomes more apparent. Sexual activity may resume following medical clearance at the Week 2 physician visit. This is a key milestone in the recovery arc.

Weeks 2 – 3: Device Integration

Shockwave therapy and vacuum device protocols are initiated if bruising has fully resolved. Normal exercise can resume. These device sessions continue for approximately four to six weeks.

Weeks 4 – 8: Stabilization

Filler integration stabilizes and the final contour emerges. The AETHRAFORM clinical team evaluates results and determines whether touch-up sessions or additional modules are indicated. The next full treatment session is typically scheduled three to six weeks after the initial procedure.

The PHALLONOX protocol is designed for men who approach enhancement with the same seriousness they bring to other aspects of their health and performance. Ideal candidates are in good general health, have realistic expectations about staged outcomes, and are committed to the full aftercare and recovery protocol.

During the private consultation, the AETHRAFORM clinical team will:

• Evaluate anatomy and discuss specific goals — girth, proportional balance, scrotal aesthetics, and functional considerations
• Review medical history, including medications, allergies, and relevant health status
• Outline a staged treatment plan with first-line and advanced options
• Set realistic expectations about the number of sessions, recovery timeline, and gradual nature of results
• Discuss all adjunctive modules including vascular support, device protocols, IV therapies, and optional peptide programmes

Every patient receives a fully personalized protocol. There is no one-size-fits-all approach — the PHALLONOX architecture is engineered around your anatomy, your goals, and your timeline. Enhancement is staged, monitored, and refined at every step.

Consultations are conducted with complete discretion and confidentiality. The AETHRAFORM clinical team understand the sensitivity of this area and maintain the highest standard of privacy throughout every phase of the patient journey — from initial inquiry through follow-up care.